Cancer Cell Scaffold for C13 MRI Hyperpolarization Studies
Project Overview
Assessing the progression and response to treatment of cancer may be possible by characterizing the metabolic state of cancer cells. Currently, our client uses MRI hyperpolarized carbon-13 labeled pyruvate to evaluate the metabolism of cancer. The objective of our project is to develop a cell scaffold for maintaining the cancer cells within a MR-compatible bioreactor. Cells must adhere and proliferate on this scaffold to sufficiently high densities and sustain viability for visualization of the pyruvate.
Team Picture
Images
Files
- Final Poster (May 1, 2011)
- Final Report (May 3, 2011)
- Mid-semester Presentation (March 3, 2011)
- PDS (March 5, 2011)
- Mid-Semester Paper (March 9, 2011)
Contact Information
Team Members
- Joshua Kolz - Team Leader
- Vanessa Grosskopf - Communicator
- Feng Chen - Co-BSAC
- Prof. Sarah Sandock - Co-BSAC
- Sarah Czaplewski - BWIG
Advisor and Client
- Prof. Brenda Ogle - Advisor
- Sean Fain - Client